Relevance,RGD ID,Symbol,Name,LOD,P Value,Trait,Sub Trait,Chr,Start,Stop,Species,Annotations,Match,Type 1000,8694196,Abfw2,Abdominal fat weight QTL 2,16.58,0.001,visceral adipose mass (VT:0010063),abdominal fat pad weight to body weight ratio (CMO:0000095),3,28249687,73249687,Rat,n/a,region,qtl 1000,61476,Aia3,Adjuvant induced arthritis QTL 3,3.9,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),4,86730991,131730991,Rat,n/a,region,qtl 1000,738031,Alc14,Alcohol consumption QTL 14,7.6,0.00003,consumption behavior trait (VT:0002069),ethanol drink intake rate to body weight ratio (CMO:0001616),4,59948935,154902892,Rat,n/a,region,qtl 1000,738016,Alc16,Alcohol consumption QTL 16,3.6,0.00015,consumption behavior trait (VT:0002069),ethanol drink intake rate to body weight ratio (CMO:0001616),4,59948935,154902892,Rat,n/a,region,qtl 1000,70200,Alc18,Alcohol consumption QTL 18,9.2,,drinking behavior trait (VT:0001422),ethanol intake volume to total fluid intake volume ratio (CMO:0001591),4,56647873,149491524,Rat,n/a,region,qtl 1000,1641833,Alc21,Alcohol consumption QTL 21,8.6,0.0001,drinking behavior trait (VT:0001422),ethanol drink intake rate (CMO:0001407),4,56698790,126192555,Rat,n/a,region,qtl 1000,1641919,Alc22,Alcohol consumption QTL 22,,0.0005,drinking behavior trait (VT:0001422),ethanol drink intake rate (CMO:0001407),4,81192555,126192555,Rat,n/a,region,qtl 1000,12879853,Am5,Aortic mass QTL 5,,0.001,aorta mass (VT:0002845),aorta weight to aorta length to body weight ratio (CMO:0002722),3,18311454,47233430,Rat,n/a,region,qtl 1000,12879868,Am6,Aortic mass QTL 6,,0.001,aorta mass (VT:0002845),aorta weight to aorta length to body weight ratio (CMO:0002722),3,31426403,70668733,Rat,n/a,region,qtl 1000,634335,Anxrr16,Anxiety related response QTL 16,7.22,,locomotor behavior trait (VT:0001392),number of entries into a discrete space in an experimental apparatus (CMO:0000960),4,93308457,167139447,Rat,n/a,region,qtl 1000,6478684,Anxrr30,Anxiety related response QTL 30,,0.00087,defecation behavior trait (VT:0010462),defecation rate (CMO:0000998),4,62753847,107753847,Rat,n/a,region,qtl 1000,6478743,Anxrr40,Anxiety related response QTL 40,,0.83076,defecation behavior trait (VT:0010462),defecation rate (CMO:0000998),4,62753847,107753847,Rat,n/a,region,qtl 1000,6478772,Anxrr49,Anxiety related response QTL 49,,0.15488,defecation behavior trait (VT:0010462),defecation rate (CMO:0000998),4,62753847,107753847,Rat,n/a,region,qtl 1000,12798520,Anxrr55,Anxiety related response QTL 55,4.45,0.01,locomotor behavior trait (VT:0001392),number of rearing movements with lid-pushing in an experimental apparatus (CMO:0002715),4,32583980,114627242,Rat,n/a,region,qtl 1000,12798523,Anxrr56,Anxiety related response QTL 56,2.83,0.05,locomotor behavior trait (VT:0001392),amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958),4,85253748,150276390,Rat,n/a,region,qtl 1000,1578655,Bmd11,Bone mineral density QTL 11,11,,femur mineral mass (VT:0010011),total volumetric bone mineral density (CMO:0001728),4,90850165,135850165,Rat,n/a,region,qtl 1000,2300179,Bmd50,Bone mineral density QTL 50,5.9,0.0001,femur mineral mass (VT:0010011),volumetric bone mineral density (CMO:0001553),4,60928534,105928534,Rat,n/a,region,qtl 1000,2313101,Bmd76,Bone mineral density QTL 76,3.6,0.0001,tibia mineral mass (VT:1000283),total volumetric bone mineral density (CMO:0001728),3,27494621,50302886,Rat,n/a,region,qtl 1000,2313093,Bmd77,Bone mineral density QTL 77,2.2,0.0001,tibia mineral mass (VT:1000283),cortical volumetric bone mineral density (CMO:0001730),3,27494621,50302886,Rat,n/a,region,qtl 1000,631647,Bp122,Blood pressure QTL 122,6.2,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),3,30684642,75684642,Rat,n/a,region,qtl 1000,631651,Bp124,Blood pressure QTL 124,3,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),4,62879517,107879517,Rat,n/a,region,qtl 1000,631556,Bp135,Blood pressure QTL 135,,0.017,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),4,78881294,117676292,Rat,n/a,region,qtl 1000,724522,Bp146,Blood pressure QTL 146,2.2,0.0021,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),4,73630210,118630210,Rat,n/a,region,qtl 1000,731172,Bp151,Blood pressure QTL 151,,0.04,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),3,18311454,47233430,Rat,n/a,region,qtl 1000,1300169,Bp177,Blood pressure QTL 177,2.96,,arterial blood pressure trait (VT:2000000),blood pressure time series experimental set point of the baroreceptor response (CMO:0002593),3,33703347,61017857,Rat,n/a,region,qtl 1000,1358885,Bp251,Blood pressure QTL 251,3.8,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),3,14489145,121056321,Rat,n/a,region,qtl 1000,1358888,Bp264,Blood pressure QTL 264,4.43,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),3,14489145,121056321,Rat,n/a,region,qtl 1000,2303168,Bp330,Blood pressure QTL 330,4.25,0.017,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),4,5214602,146446691,Rat,n/a,region,qtl 1000,2306899,Bp338,Blood pressure QTL 338,,0.071,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),4,81006124,120102625,Rat,n/a,region,qtl 1000,61356,Bp37,Blood pressure QTL 37,3,,blood pressure trait (VT:0000183),systolic blood pressure (CMO:0000004),3,30684642,75684642,Rat,n/a,region,qtl 1000,631568,Bp92,Blood pressure QTL 92,2.2,0.005,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),3,1,39874793,Rat,n/a,region,qtl 1000,70191,BpQTLcluster4,Blood pressure QTL cluster 4,3,,arterial blood pressure trait (VT:2000000),absolute change in mean arterial blood pressure (CMO:0000533),3,10778704,50302886,Rat,n/a,region,qtl 1000,70191,BpQTLcluster4,Blood pressure QTL cluster 4,3,,arterial blood pressure trait (VT:2000000),absolute change in systolic blood pressure (CMO:0000607),3,10778704,50302886,Rat,n/a,region,qtl 1000,70192,BpQTLcluster5,Blood pressure QTL cluster 5,4.183,,arterial blood pressure trait (VT:2000000),diastolic blood pressure (CMO:0000005),4,62933508,114921294,Rat,n/a,region,qtl 1000,70192,BpQTLcluster5,Blood pressure QTL cluster 5,4.183,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),4,62933508,114921294,Rat,n/a,region,qtl 1000,70192,BpQTLcluster5,Blood pressure QTL cluster 5,4.183,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),4,62933508,114921294,Rat,n/a,region,qtl 1000,70192,BpQTLcluster5,Blood pressure QTL cluster 5,4.183,,arterial blood pressure trait (VT:2000000),percent change in mean arterial blood pressure (CMO:0002035),4,62933508,114921294,Rat,n/a,region,qtl 1000,70192,BpQTLcluster5,Blood pressure QTL cluster 5,4.183,,arterial blood pressure trait (VT:2000000),percent change in systolic blood pressure (CMO:0000747),4,62933508,114921294,Rat,n/a,region,qtl 1000,70192,BpQTLcluster5,Blood pressure QTL cluster 5,4.183,,arterial blood pressure trait (VT:2000000),absolute change in pulse pressure (CMO:0001882),4,62933508,114921294,Rat,n/a,region,qtl 1000,70192,BpQTLcluster5,Blood pressure QTL cluster 5,4.183,,arterial blood pressure trait (VT:2000000),absolute change in mean arterial blood pressure (CMO:0000533),4,62933508,114921294,Rat,n/a,region,qtl 1000,1578657,Bss12,Bone structure and strength QTL 12,8.9,,femur morphology trait (VT:0000559),femoral neck cross-sectional area (CMO:0001697),4,60220938,105220938,Rat,n/a,region,qtl 1000,1578658,Bss13,Bone structure and strength QTL 13,8,,femur strength trait (VT:0010010),femoral neck polar moment of inertia (CMO:0001670),4,60220938,105220938,Rat,n/a,region,qtl 1000,1578670,Bss14,Bone structure and strength QTL 14,16.4,,femur morphology trait (VT:0000559),bone trabecular cross-sectional area (CMO:0002311),4,87327165,132327165,Rat,n/a,region,qtl 1000,1578662,Bss15,Bone structure and strength QTL 15,19.6,,femur width (VT:1000666),femoral neck width (CMO:0001695),4,87327165,132327165,Rat,n/a,region,qtl 1000,2313049,Bss72,Bone structure and strength QTL 72,2.6,0.0001,tibia area (VT:1000281),tibia midshaft cross-sectional area (CMO:0001717),3,27494621,50302886,Rat,n/a,region,qtl 1000,2313079,Bss73,Bone structure and strength QTL 73,1.5,,tibia size trait (VT:0100001),tibia midshaft cross-sectional area (CMO:0001717),3,27494621,50302886,Rat,n/a,region,qtl 1000,2313076,Bss74,Bone structure and strength QTL 74,2,0.0001,tibia strength trait (VT:1000284),tibia total energy absorbed before break (CMO:0001736),3,27494621,50302886,Rat,n/a,region,qtl 1000,8694386,Bw159,Body weight QTL 159,4.52,0.001,body lean mass (VT:0010483),lean tissue morphological measurement (CMO:0002184),3,28249687,73249687,Rat,n/a,region,qtl 1000,11565451,Bw177,Body weight QTL 177,,0.002,body mass (VT:0001259),body weight (CMO:0000012),3,31426403,70668733,Rat,n/a,region,qtl 1000,12879849,Bw180,Body weight QTL 180,,0.037,body mass (VT:0001259),body weight (CMO:0000012),3,18311454,47233430,Rat,n/a,region,qtl 1000,70167,Bw22,Body weight QTL 22,3.1,,body mass (VT:0001259),body weight (CMO:0000012),4,76647384,117676292,Rat,n/a,region,qtl 1000,1354589,Bw31,Body weight QTL 31,3.3,,body mass (VT:0001259),body weight (CMO:0000012),3,33703347,78196190,Rat,n/a,region,qtl 1000,1354604,Bw36,Body weight QTL 36,2.9,,body mass (VT:0001259),body weight (CMO:0000012),3,33703347,104104347,Rat,n/a,region,qtl 1000,1357342,Bw40,Body weight QTL 40,,0.001,body mass (VT:0001259),body weight (CMO:0000012),4,76647384,117676292,Rat,n/a,region,qtl 1000,1549839,Bw52,Body weight QTL 52,,0.0001,body mass (VT:0001259),body weight gain (CMO:0000420),4,61697658,115089733,Rat,n/a,region,qtl 1000,1549843,Bw53,Body weight QTL 53,,0.0001,body mass (VT:0001259),body weight gain (CMO:0000420),4,61697658,103194791,Rat,n/a,region,qtl 1000,61419,Cia11,Collagen induced arthritis QTL 11,5.6,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),3,30356773,98535386,Rat,n/a,region,qtl 1000,1298073,Cm13,Cardiac mass QTL 13,2.5,,heart mass (VT:0007028),heart wet weight (CMO:0000069),3,25013911,38192233,Rat,n/a,region,qtl 1000,70216,Cm14,Cardiac mass QTL 14,2.1,,heart mass (VT:0007028),heart wet weight (CMO:0000069),3,31172320,163586636,Rat,n/a,region,qtl 1000,2301400,Cm68,Cardiac mass QTL 68,,0.001,heart mass (VT:0007028),heart wet weight to body weight ratio (CMO:0002408),3,31426403,70668733,Rat,n/a,region,qtl 1000,631676,Cm8,Cardiac mass QTL 8,7.03,0.0001,aorta mass (VT:0002845),aorta weight (CMO:0000076),3,16954708,61954708,Rat,n/a,region,qtl 1000,12879850,Cm91,Cardiac mass QTL 91,,0.001,heart mass (VT:0007028),heart wet weight to body weight ratio (CMO:0002408),3,18311454,47233430,Rat,n/a,region,qtl 1000,12879851,Cm92,Cardiac mass QTL 92,,0.001,heart left ventricle mass (VT:0007031),heart left ventricle weight to body weight ratio (CMO:0000530),3,18311454,47233430,Rat,n/a,region,qtl 1000,12879852,Cm93,Cardiac mass QTL 93,,0.001,heart right ventricle mass (VT:0007033),heart right ventricle weight to body weight ratio (CMO:0000914),3,18311454,47233430,Rat,n/a,region,qtl 1000,12879866,Cm94,Cardiac mass QTL 94,,0.001,heart left ventricle mass (VT:0007031),heart left ventricle weight to body weight ratio (CMO:0000530),3,31426403,70668733,Rat,n/a,region,qtl 1000,12879867,Cm95,Cardiac mass QTL 95,,0.047,heart right ventricle mass (VT:0007033),heart right ventricle weight to body weight ratio (CMO:0000914),3,31426403,70668733,Rat,n/a,region,qtl 1000,1354590,Despr11,Despair related QTL 11,,0.000031,locomotor behavior trait (VT:0001392),amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958),3,28468571,73468571,Rat,n/a,region,qtl 1000,2317587,Eae26,Experimental allergic encephalomyelitis QTL 26,,,nervous system integrity trait (VT:0010566),experimental autoimmune encephalomyelitis severity score (CMO:0001419),4,88656681,103194984,Rat,n/a,region,qtl 1000,61330,Eau1,Experimental allergic uveoretinitis QTL 1,,0.0003,uvea integrity trait (VT:0010551),experimental autoimmune uveitis score (CMO:0001504),4,70362013,132642728,Rat,n/a,region,qtl 1000,1576305,Emca6,Estrogen-induced mammary cancer QTL 6,5.8,,mammary gland integrity trait (VT:0010552),mammary tumor number (CMO:0000343),4,44463720,155883716,Rat,n/a,region,qtl 1000,1576316,Ept5,Estrogen-induced pituitary tumorigenesis QTL 5,3.8,,pituitary gland mass (VT:0010496),pituitary gland wet weight (CMO:0000853),4,83428419,177635233,Rat,n/a,region,qtl 1000,1354612,Foco1,Food consumption QTL 1,8.87,,eating behavior trait (VT:0001431),food intake rate (CMO:0000427),4,44463908,148090542,Rat,n/a,region,qtl 1000,2312567,Glom19,Glomerulus QTL 19,1.9,0.006,kidney glomerulus morphology trait (VT:0005325),index of glomerular damage (CMO:0001135),4,45456990,146803430,Rat,n/a,region,qtl 1000,1358202,Gluco11,Glucose level QTL 11,2.4,0.02,adipocyte glucose uptake trait (VT:0004185),absolute change in adipocyte glucose uptake (CMO:0000873),4,85379421,167139601,Rat,n/a,region,qtl 1000,1582232,Gluco25,Glucose level QTL 25,3.6,0.0023,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),4,85253748,148090731,Rat,n/a,region,qtl 1000,2303593,Gluco46,Glucose level QTL 46,3,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),3,28468571,73468571,Rat,n/a,region,qtl 1000,2316958,Gluco58,Glucose level QTL 58,10,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),4,11320076,180699135,Rat,n/a,region,qtl 1000,737818,Hcar12,Hepatocarcinoma resistance QTL 12,2.6,,liver integrity trait (VT:0010547),volume of individual liver tumorous lesion (CMO:0001078),3,29463235,118376539,Rat,n/a,region,qtl 1000,631662,Hcar2,Hepatocarcinoma resistance QTL 2,3.1,0.0003,liver integrity trait (VT:0010547),volume of individual liver tumorous lesion (CMO:0001078),4,78878504,123878504,Rat,n/a,region,qtl 1000,634344,Hcar7,Hepatocarcinoma resistance QTL 7,7.8,,liver integrity trait (VT:0010547),liver tumorous lesion area to total liver area ratio (CMO:0001075),4,70808386,115808386,Rat,n/a,region,qtl 1000,634344,Hcar7,Hepatocarcinoma resistance QTL 7,7.8,,liver integrity trait (VT:0010547),liver tumorous lesion number (CMO:0001068),4,70808386,115808386,Rat,n/a,region,qtl 1000,1358905,Hrtrt17,Heart rate QTL 17,5.9,0.000014,heart pumping trait (VT:2000009),heart rate (CMO:0000002),3,10861912,89878372,Rat,n/a,region,qtl 1000,1300139,Hrtrt6,Heart rate QTL 6,2.85,,heart pumping trait (VT:2000009),heart rate (CMO:0000002),4,39524264,116179656,Rat,n/a,region,qtl 1000,631674,Iddm14,Insulin dependent diabetes mellitus QTL 14,,,blood glucose amount (VT:0000188),plasma glucose level (CMO:0000042),4,64528739,157573521,Rat,n/a,region,qtl 1000,61364,Iddm2,Insulin dependent diabetes mellitus QTL 2,,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),4,78885890,102684881,Rat,n/a,region,qtl 1000,8655961,Kidm43,Kidney mass QTL 43,18,,kidney mass (VT:0002707),both kidneys wet weight (CMO:0000085),4,36303261,103194984,Rat,n/a,region,qtl 1000,10401810,Kidm53,Kidney mass QTL 53,,,kidney mass (VT:0002707),both kidneys wet weight to body weight ratio (CMO:0000340),3,8227194,47233430,Rat,n/a,region,qtl 1000,11565452,Kidm57,Kidney mass QTL 57,,0.001,kidney mass (VT:0002707),both kidneys wet weight to body weight ratio (CMO:0000340),3,31426403,70668733,Rat,n/a,region,qtl 1000,12879854,Kidm63,Kidney mass QTL 63,,0.001,kidney mass (VT:0002707),both kidneys wet weight to body weight ratio (CMO:0000340),3,18311454,47233430,Rat,n/a,region,qtl 1000,2298542,Neuinf11,Neuroinflammation QTL 11,3.9,,nervous system integrity trait (VT:0010566),"spinal cord complement component 1, q subcomponent, B chain mRNA level (CMO:0002126)",3,15005422,76927699,Rat,n/a,region,qtl 1000,2302051,Pia28,Pristane induced arthritis QTL 28,5.3,0.001,blood autoantibody amount (VT:0003725),serum immunoglobulin G-type rheumatoid factor level relative to an arbitrary reference serum (CMO:0002112),4,73630210,118630210,Rat,n/a,region,qtl 1000,2302055,Pia30,Pristane induced arthritis QTL 30,3.5,0.001,blood autoantibody amount (VT:0003725),serum immunoglobulin M-type rheumatoid factor level relative to an arbitrary reference serum (CMO:0002111),3,27936919,72936919,Rat,n/a,region,qtl 1000,61418,Pia5,Pristane induced arthritis QTL 5,4.5,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),4,62277855,128289560,Rat,n/a,region,qtl 1000,738015,Pia9,Pristane induced arthritis QTL 9,4.5,0.048,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),4,80694870,125694870,Rat,n/a,region,qtl 1000,8552950,Pigfal12,Plasma insulin-like growth factor 1 level QTL 12,7.3,,blood insulin-like growth factor amount (VT:0010479),plasma insulin-like growth factor 1 level (CMO:0001299),3,28249687,73249687,Rat,n/a,region,qtl 1000,631832,Sach1,Saccharin preference QTL 1,2.7,0.02,consumption behavior trait (VT:0002069),calculated saccharin drink intake volume (CMO:0001600),3,27494621,44188411,Rat,n/a,region,qtl 1000,738009,Sach4,Saccharine consumption QTL 4,4.9,0.000016,consumption behavior trait (VT:0002069),saccharin intake volume to total fluid intake volume ratio (CMO:0001601),4,59948935,154902892,Rat,n/a,region,qtl 1000,634311,Sach7,Saccharin preference QTL 7,,,taste sensitivity trait (VT:0001986),saccharin intake volume to total fluid intake volume ratio (CMO:0001601),4,57114432,102114432,Rat,n/a,region,qtl 1000,1354660,Salc1,Saline consumption QTL 1,11.26,,drinking behavior trait (VT:0001422),saline drink intake rate (CMO:0001627),4,44463908,148090542,Rat,n/a,region,qtl 1000,631689,Scl4,Serum cholesterol level QTL 4,1.9,0.008,blood cholesterol amount (VT:0000180),serum total cholesterol level (CMO:0000363),4,95174120,140174120,Rat,n/a,region,qtl 1000,2290452,Scl56,Serum cholesterol level QTL 56,2.26,,blood cholesterol amount (VT:0000180),plasma total cholesterol level (CMO:0000585),3,1,91609953,Rat,n/a,region,qtl 1000,2312664,Scl62,Serum cholesterol level QTL 62,,0.05,blood cholesterol amount (VT:0000180),serum total cholesterol level (CMO:0000363),3,1,38710544,Rat,n/a,region,qtl 1000,10450794,Scl69,Serum cholesterol level QTL 69,6.3,0.001,blood LDL cholesterol amount (VT:0000181),blood low density lipoprotein cholesterol level (CMO:0000053),3,20714090,65714090,Rat,n/a,region,qtl 1000,10450804,Scl70,Serum cholesterol level QTL 70,4.7,0.001,blood LDL cholesterol amount (VT:0000181),blood low density lipoprotein cholesterol level (CMO:0000053),3,20714090,65714090,Rat,n/a,region,qtl 1000,9590136,Scort3,Serum corticosterone level QTL 3,23.37,0.001,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),3,28249687,73249687,Rat,n/a,region,qtl 1000,1358363,Sradr3,Stress Responsive Adrenal Weight QTL 3,6.19,,adrenal gland mass (VT:0010420),both adrenal glands wet weight (CMO:0000164),4,57486946,102486946,Rat,n/a,region,qtl 1000,1358352,Srcrt3,Stress Responsive Cort QTL 3,2.29,,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),4,38465774,146803430,Rat,n/a,region,qtl 1000,631646,Stl4,Serum triglyceride level QTL 4,6.5,0.0001,blood triglyceride amount (VT:0002644),plasma triglyceride level (CMO:0000548),4,73169846,132642728,Rat,n/a,region,qtl 1000,1298082,Stresp4,Stress response QTL 4,,,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),4,50119848,146803430,Rat,n/a,region,qtl 1000,9590286,Uminl1,Urine mineral level QTL 1,3.5,0.001,urine mineral amount (VT:0015086),urine electrolyte level (CMO:0000593),3,28249687,73249687,Rat,n/a,region,qtl 1000,70177,Xhs1,X-ray hypersensitivity QTL 1,25.1,,intestine integrity trait (VT:0010554),post-insult time to onset of moribundity (CMO:0001896),4,82798864,152731274,Rat,n/a,region,qtl 1000,634334,Xhs3,X-ray hypersensitivity QTL 3,10,,intestine integrity trait (VT:0010554),post-insult time to onset of moribundity (CMO:0001896),4,84728680,129854654,Rat,n/a,region,qtl